This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name : 
Invitrogen
other brands : 
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type : 
antibody
product name : 
PLAC2 Polyclonal Antibody
catalog : 
PA5-21045
quantity : 
100 ug
price : 
US 464.00
clonality : 
polyclonal
host : 
domestic rabbit
conjugate : 
nonconjugated
reactivity : 
human
application : 
western blot, immunocytochemistry
product information
Product Type : 
Antibody
Product Name : 
PLAC2 Polyclonal Antibody
Catalog # : 
PA5-21045
Quantity : 
100 ug
Price : 
US 464.00
Clonality : 
Polyclonal
Purity : 
Antigen affinity chromatography
Host : 
Rabbit
Reactivity : 
Human
Applications : 
Immunocytochemistry: 10 ug/mL, Western Blot: 1-2 ug/mL
Species : 
Human
Isotype : 
IgG
Storage : 
Maintain refrigerated at 2-8 C for up to 3 months. For long term storage store at -20 C
Description : 
PLAC2 (placenta-specific protein 2) is a 151 amino acid protein that is encoded by a gene located on human chromosome 19p13. Based on its amino acid sequence, PLAC2 is predicted to be a multi-pass membrane protein. There are no reported studies or functions reported for this protein.
Immunogen : 
A 17 amino acid peptide near the center of human PLAC2.
Format : 
Liquid
Applications w/Dilutions : 
Immunocytochemistry: 10 ug/mL, Western Blot: 1-2 ug/mL
Aliases : 
LINC00036; NCRNA00036; onco-lncRNA-16; PLAC2; PP10933; TINCR; tissue differentiation-inducing non-protein coding RNA
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments
